| |
bcl-2 expression (I.H) |
| |
Total No. (%) |
Positive bcl-2 No. (%) |
Negative bcl-2 No. (%) |
P value |
| Mean Age±SD |
50.7± 13.2 |
47.4 ±12.7 |
53.2 ±13.2 |
0.47 |
| Sex |
|
0.6 |
| Male |
24 (60.0%) |
10 (41.7%) |
14 (58.3%) |
| Female |
16 (40.0%) |
8 (50.0%) |
8 (50.0%) |
| Size |
|
0.14 |
| <5 |
13 (32.5%) |
8 (61.5%) |
5 (38.5%) |
|
| >5 |
27 (67.5%) |
10 (37.0%) |
17 (63.0%) |
| Site |
|
0.31 |
| Antrum |
22 (55.0%) |
12 (54.5%) |
10 (45.5%) |
|
| Body |
13 (32.5%) |
5 (38.8%) |
8 (61.5%) |
| Cardia |
5 (12.5%) |
1 (20.0%) |
4 (80.0%) |
| Gross (shape) |
|
0.5 |
| Ulcerating |
22 (55.0%) |
9 (37.5%) |
15 (62.5%) |
| Infiltrating |
7 (17.5%) |
4 (57.1%) |
3 (42.5%) |
| Polypoid |
9 (22.5%) |
5 (55.6%) |
4 (44.4%) |
| Type |
|
0.15 |
| Epithelial tumor |
32 (80.0%) |
12 (37.5%) |
20 (62.5%) |
|
| Stromal tumor |
3 (07.5%) |
2 (66.7%) |
1 (33.3%) |
| NHL |
5 (12.5%) |
4 (80.0%) |
1 (20.0%) |
| Grade |
|
0.026 |
| Low |
8 (20.0%) |
7 (87.5%) |
1 (12.5%) |
|
| Intermediate |
20 (50.0%) |
7 (35.0%) |
13 (65.0%) |
| High |
12 (30.0%) |
4 (33.3%) |
8 (66.7%) |
| Total |
40 (100%) |
18 (45.0%) |
22 (55.0%) |
|
|
